SciELO - Scientific Electronic Library Online

 issue60The mile-stone of PET radiopharmaceuticals developmentPhosphorous-32 and Yttrium-90 as options in the treatment of metastatic bone pain author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand



  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO



On-line version ISSN 2075-5635


SIGNORE, Alberto et al. Molecular imaging of cancer microenvironment. Nucleus [online]. 2016, n.60, pp. 18-23. ISSN 2075-5635.

In the last decades, researchers have been focusing on cancer cells looking for novel targets, however, tumours grow in a host environment that either contribute to or inhibit tumour expansion and metastatization. Several efforts have been focused on cancer microenvironment for diagnostic and therapeutic purposes. Nuclear medicine can contribute to understand the complexity and role of tumour microenvironment by imaging several of its components (chemokine receptors, immune cells, stromal antigens, vascular factors, etc). In a tumour, each microenvironment component offers many potential targets for several drugs or radiopharmaceuticals. Cancer may be studied using different strategies from different viewpoints: imaging tumour markers or differentiating markers for diagnostic purposes in order to plan personalized therapies (receptor agonists or superagonists); imaging tumour stroma and vascularization to monitor cell adhesion, metastases, angiogenesis and hypoxia; imaging the host response of cancer cells to monitor efficacy of immunotherapeutic strategies

Keywords : lymphocytes; images; molecules; lymphokines; metastases; diagnosis; therapy; endothelium; growth.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License